Conv. Plasma
Nigella Sativa

All HCQ studies
Meta analysis
study COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Effects of chloroquine on viral infections: an old drug against today's diseases

Savarino et al., Lancet Infect. Dis., doi:10.1016/S1473-3099(03)00806-5
Nov 2003  
  Source   PDF   All Studies   Meta AnalysisMeta
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
*, now with p < 0.00000000001 from 411 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments.
Discussion/review noting that CQ exerts antiviral effects, inhibiting the replication of several viruses including members of the flaviviruses, retroviruses, and coronaviruses. Notes that CQ has immunomodulatory effects, suppressing the production/release of tumour necrosis factor α and interleukin 6, which mediate the inflammatory complications of several viral diseases.
Savarino et al., 1 Nov 2003, peer-reviewed, 5 authors.
This PaperHCQAll
Abstract: Personal view Antiviral effects of chloroquine Effects of chloroquine on viral infections: an old drug against today’s diseases? Andrea Savarino, Johan R Boelaert, Antonio Cassone, Giancarlo Majori, and Roberto Cauda. Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemical properties that might be applied against some viral infections. Chloroquine exerts direct antiviral effects, inhibiting pH-dependent steps of the replication of several viruses including members of the flaviviruses, retroviruses, and coronaviruses. Its best-studied effects are those against HIV replication, which are being tested in clinical trials. Moreover, chloroquine has immunomodulatory effects, suppressing the production/release of tumour necrosis factor  and interleukin 6, which mediate the inflammatory complications of several viral diseases. We review the available information on the effects of chloroquine on viral infections, raising the question of whether this old drug may experience a revival in the clinical management of viral diseases such as AIDS and severe acute respiratory syndrome, which afflict mankind in the era of globalisation. Endocytosis of viral particles Transport of endocytosed virus Virus uncoating Replication/ transcription of viral nucleic acids Post-translational processing of envelope glycoproteins in the Golgi Transport of envelope components Assembly/ budding Lancet Infect Dis 2003; 3: 722–27 Chloroquine is a 9-aminoquinoline that has been known since 1934. Specifically synthesised to be used as an antimalarial agent, chloroquine was subsequently shown to have immunomodulatory properties that have encouraged its application in the treatment of autoimmune diseases such as rheumatoid arthritis. For this specific pathology, chloroquine and its hydroxy-analogue hydroxychloroquine have represented a valid contribution to the available pharmacological tools, since they proved able to slow down the progress of the disease while showing limited toxicity.1 Unfortunately, chloroquine is being gradually dismissed from antimalarial therapy and prophylaxis, due to the continuous emergence of chloroquine-resistant Plasmodium falciparum strains. However, the tolerability, low cost, and immunomodulatory properties of chloroquine/hydroxychloroquine are associated with biochemical effects that suggest a potential use in viral infections, some of whose symptoms may result from the inflammatory response.2,3 We raise the question of whether this old drug whose parent compound, quinine, was isolated in the late 19th century from the bark of the tropical cinchona tree, may experience a revival in the clinical management of viral diseases of the era of globalisation. General biochemical and cellular effects of chloroquine Both chloroquine and hydroxychloroquine are weak bases that are known to affect acid vesicles leading to dysfunction of several enzymes. Extracellularly, chloroquine/hydroxychloroquine is present mostly in a protonated form that, due 722 Transport of newly formed viral particles Assembly/budding Exocytosis of viral particles Figure 1. Steps of the replication of different viruses affected by chloroquine (marked by red rectangles). Chloroquine inhibits the replication of different viruses either at the early or late stages of viral replication. to its positive charge, is incapable of crossing the plasma membrane. However, the non-protonated..
{ 'indexed': {'date-parts': [[2024, 5, 14]], 'date-time': '2024-05-14T18:35:37Z', 'timestamp': 1715711737992}, 'reference-count': 61, 'publisher': 'Elsevier BV', 'issue': '11', 'license': [ { 'start': { 'date-parts': [[2003, 11, 1]], 'date-time': '2003-11-01T00:00:00Z', 'timestamp': 1067644800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': ''}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2003, 11]]}, 'DOI': '10.1016/s1473-3099(03)00806-5', 'type': 'journal-article', 'created': { 'date-parts': [[2003, 10, 28]], 'date-time': '2003-10-28T04:21:37Z', 'timestamp': 1067314897000}, 'page': '722-727', 'source': 'Crossref', 'is-referenced-by-count': 907, 'title': "Effects of chloroquine on viral infections: an old drug against today's diseases", 'prefix': '10.1016', 'volume': '3', 'author': [ {'given': 'Adrea', 'family': 'Savarino', 'sequence': 'first', 'affiliation': []}, {'given': 'John R', 'family': 'Boelaert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antonio', 'family': 'Cassone', 'sequence': 'additional', 'affiliation': []}, {'given': 'Giancario', 'family': 'Majori', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roberto', 'family': 'Cauda', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/S1473-3099(03)00806-5_bib1', 'first-page': '2919', 'article-title': 'Canadian Consensus Conference on hydroxychloroquine', 'volume': '27', 'year': '2000', 'journal-title': 'J Rheumatol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib2', 'doi-asserted-by': 'crossref', 'first-page': '131', 'DOI': '10.1016/S1386-6532(00)00139-6', 'article-title': 'The anti-HIV-1 activity of chloroquine', 'volume': '20', 'author': 'Savarino', 'year': '2001', 'journal-title': 'J Clin Virol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib3', 'doi-asserted-by': 'crossref', 'first-page': '137', 'DOI': '10.1016/S1386-6532(00)00140-2', 'article-title': 'The potential place of chloroquine in the treatment of HIV-1–infected ' 'patients', 'volume': '20', 'author': 'Boelaert', 'year': '2001', 'journal-title': 'J Clin Virol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib4', 'doi-asserted-by': 'crossref', 'first-page': '656', 'DOI': '10.1083/jcb.90.3.656', 'article-title': 'Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake ' 'into lysosomes of weakly basic substances', 'volume': '90', 'author': 'Ohkuma', 'year': '1981', 'journal-title': 'J Cell Biol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib5', 'first-page': '212', 'article-title': 'Movements of vesicles in eukaryotic cells: role of intravesicle protons ' 'as a fuel and modulation of their concentration by drugs or metabolic ' 'changes', 'volume': '489', 'author': 'Pescarmona', 'year': '1998', 'journal-title': 'MRS Bull'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib6', 'doi-asserted-by': 'crossref', 'first-page': '1245', 'DOI': '10.1016/S0006-2952(00)00270-7', 'article-title': 'Reversal of MRP-mediated doxorubicin resistance with quinoline-based ' 'drugs', 'volume': '59', 'author': 'Vezmar', 'year': '2000', 'journal-title': 'Biochem Pharmacol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib7', 'doi-asserted-by': 'crossref', 'first-page': '733', 'DOI': '10.1016/S0006-2952(98)00217-2', 'article-title': 'Direct binding of chloroquine to the multidrug resistance protein ' '(MRP): possible role for MRP in chloroquine drug transport and ' 'resistance in tumor cells', 'volume': '56', 'author': 'Vezmar', 'year': '1998', 'journal-title': 'Biochem Pharmacol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib8', 'doi-asserted-by': 'crossref', 'first-page': '351', 'DOI': '10.1172/JCI115301', 'article-title': 'Chloroquine inhibits the intracellular multiplication of Legionella ' 'pneumophila by limiting the availability of iron. A potential new ' 'mechanism for the therapeutic effect of chloroquine against ' 'intracellular pathogens', 'volume': '88', 'author': 'Byrd', 'year': '1991', 'journal-title': 'J Clin Invest'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib9', 'doi-asserted-by': 'crossref', 'first-page': '36', 'DOI': '10.1016/S0162-0134(02)00633-5', 'article-title': 'Changes in function of iron-loaded alveolar macrophages after in vivo ' 'administration of desferrioxamine and/or chloroquine', 'volume': '94', 'author': 'Legssyer', 'year': '2003', 'journal-title': 'J Inorg Biochem'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib10', 'doi-asserted-by': 'crossref', 'first-page': '783', 'DOI': '10.1128/JVI.72.1.783-788.1998', 'article-title': 'Mechanism of Borna disease virus entry into cells', 'volume': '72', 'author': 'Gonzalez-Dunia', 'year': '1998', 'journal-title': 'J Virol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib11', 'doi-asserted-by': 'crossref', 'first-page': '12634', 'DOI': '10.1128/JVI.76.24.12634-12645.2002', 'article-title': 'Cytoplasmic trafficking of minute virus of mice: low-pH requirement, ' 'routing to late endosomes, and proteasome interaction', 'volume': '76', 'author': 'Ros', 'year': '2002', 'journal-title': 'J Virol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib12', 'doi-asserted-by': 'crossref', 'first-page': '12866', 'DOI': '10.1128/JVI.76.24.12866-12876.2002', 'article-title': 'Endocytosis is a critical step in entry of subgroup B avian leukosis ' 'viruses', 'volume': '76', 'author': 'Diaz-Griffero', 'year': '2000', 'journal-title': 'J Virol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib13', 'doi-asserted-by': 'crossref', 'first-page': '261', 'DOI': '10.1159/000024948', 'article-title': 'Examination of potential inhibitors of hepatitis A virus uncoating', 'volume': '41', 'author': 'Bishop', 'year': '1998', 'journal-title': 'Intervirology'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib14', 'doi-asserted-by': 'crossref', 'first-page': '313', 'DOI': '10.1099/0022-1317-49-4-313', 'article-title': 'Weak bases affect late stages of Mayaro virus replication cycle in ' 'vertebrate cells', 'volume': '49', 'author': 'Ferreira', 'year': '2000', 'journal-title': 'J Med Microbiol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib15', 'doi-asserted-by': 'crossref', 'first-page': '1236', 'DOI': '10.1128/JVI.75.3.1236-1251.2001', 'article-title': 'Characterization of herpes simplex virus-containing organelles by ' 'subcellular fractionation: role for organelle acidification in assembly ' 'of infectious particles', 'volume': '75', 'author': 'Harley', 'year': '2001', 'journal-title': 'J Virol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib16', 'doi-asserted-by': 'crossref', 'first-page': '450', 'DOI': '10.1016/0042-6822(90)90099-D', 'article-title': 'Acidotropic amines inhibit proteolytic processing of flavivirus prM ' 'protein', 'volume': '174', 'author': 'Randolph', 'year': '1990', 'journal-title': 'Virology'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib17', 'doi-asserted-by': 'crossref', 'first-page': '481', 'DOI': '10.1089/aid.1990.6.481', 'article-title': 'Inhibition of human immunodeficiency virus infectivity by chloroquine', 'volume': '6', 'author': 'Tsai', 'year': '1990', 'journal-title': 'AIDS Res Hum Retroviruses'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib18', 'doi-asserted-by': 'crossref', 'first-page': '1111', 'DOI': '10.1016/S0140-6736(03)12888-7', 'article-title': 'Sarcoidosis', 'volume': '361', 'author': 'Baughman', 'year': '2003', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib19', 'doi-asserted-by': 'crossref', 'first-page': '4901', 'DOI': '10.4049/jimmunol.158.10.4901', 'article-title': 'Chloroquine inhibits processing of tumor necrosis factor in ' 'lipopolysaccharidestimulated RAW 264·7 macrophages', 'volume': '158', 'author': 'Jeong', 'year': '1997', 'journal-title': 'J Immunol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib20', 'doi-asserted-by': 'crossref', 'first-page': '357', 'DOI': '10.1016/S0306-3623(97)00269-3', 'article-title': 'Antimalarial drugs inhibit phospholipase A2 activation and induction of ' 'interleukinβ and tumor necrosis factor α in macrophages', 'volume': '30', 'author': 'Bondeson', 'year': '1998', 'journal-title': 'General Pharmacol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib21', 'first-page': '55', 'article-title': 'Chloroquine and hydroxychloroquine equally affect tumor necrosis ' 'factor-α, interleukin 6 and interferon-γ production by peripheral blood ' 'mononuclear cells', 'volume': '24', 'author': 'Van den Borne', 'year': '1997', 'journal-title': 'J Rheumatol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib22', 'first-page': 'R1058', 'article-title': 'Chloroquine inhibits proinflammatory cytokine release into human whole ' 'blood', 'volume': '274', 'author': 'Karres', 'year': '1998', 'journal-title': 'Am J Physiol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib23', 'first-page': '127', 'article-title': 'Chloroquine-induced inhibition of the production of TNF, but not of ' 'IL-6, is affected by disruption of iron metabolism', 'volume': '80', 'author': 'Picot', 'year': '1993', 'journal-title': 'Immunology'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib24', 'doi-asserted-by': 'crossref', 'first-page': '1534', 'DOI': '10.4049/jimmunol.165.3.1534', 'article-title': 'Chloroquine interferes with lipopolysaccharide-induced TNF-α gene ' 'expression by a nonlysosomotropic mechanism', 'volume': '165', 'author': 'Weber', 'year': '2000', 'journal-title': 'J Immunol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib25', 'doi-asserted-by': 'crossref', 'first-page': '83', 'DOI': '10.1046/j.0019-2805.2001.01339.x', 'article-title': 'Chloroquine decreases cell-surface expression of tumour necrosis factor ' 'receptors in human histiocytic U-937 cells', 'volume': '105', 'author': 'Jeong', 'year': '2002', 'journal-title': 'Immunol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib26', 'doi-asserted-by': 'crossref', 'first-page': '235', 'DOI': '10.1080/09629350020025755', 'article-title': 'Permeability characteristics of human endothelial monolayers seeded on ' 'different extracellular matrix proteins', 'volume': '9', 'author': 'Nooteboom', 'year': '2000', 'journal-title': 'Mediators Inflamm'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib27', 'first-page': '292', 'article-title': 'Ocular safety of hydroxychloroquine', 'volume': '23', 'author': 'Bernstein', 'year': '1991', 'journal-title': 'Ann Ophthalmol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib28', 'doi-asserted-by': 'crossref', 'first-page': '25', 'DOI': '10.1016/0002-9343(83)91267-6', 'article-title': 'Ophthalmologic considerations and testing in patients receiving ' 'long-term antimalarial therapy', 'volume': '75', 'author': 'Bernstein', 'year': '1983', 'journal-title': 'Am J Med'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib29', 'first-page': '21', 'article-title': '(Hydroxy)-chloroquine retinal toxicity: two case reports and safety ' 'guidelines', 'volume': '284', 'author': 'Herman', 'year': '2002', 'journal-title': 'Bull Soc Belge Ophtalmol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib30', 'doi-asserted-by': 'crossref', 'first-page': '813', 'DOI': '10.1016/S0140-6736(01)06004-4', 'article-title': 'Ocular toxicity and antenatal exposure to chloroquine or ' 'hydroxychloroquine for rheumatic diseases', 'volume': '358', 'author': 'Klinger', 'year': '2001', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib31', 'doi-asserted-by': 'crossref', 'first-page': '91', 'DOI': '10.1089/aid.1993.9.91', 'article-title': 'Inhibition of human immunodeficiency virus type 1 replication by ' 'hydroxychloroquine in T cells and monocytes', 'volume': '9', 'author': 'Sperber', 'year': '1993', 'journal-title': 'AIDS Res Hum Retroviruses'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib32', 'doi-asserted-by': 'crossref', 'first-page': '45', 'DOI': '10.1016/S0165-2478(98)00096-0', 'article-title': 'Chloroquine inhibits HIV-1 replication in human peripheral blood ' 'lymphocytes', 'volume': '64', 'author': 'Pardridge', 'year': '1998', 'journal-title': 'Immunol Lett'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib33', 'doi-asserted-by': 'crossref', 'first-page': '2221', 'DOI': '10.1097/00002030-200111230-00002', 'article-title': 'Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum ' 'of activity', 'volume': '15', 'author': 'Savarino', 'year': '2001', 'journal-title': 'AIDS'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib34', 'doi-asserted-by': 'crossref', 'first-page': '622', 'DOI': '10.1016/0149-2918(95)80039-5', 'article-title': 'Hydroxychloroquine treatment of patients with human immunodeficiency ' 'virus type 1', 'volume': '17', 'author': 'Sperber', 'year': '1995', 'journal-title': 'Clin Ther'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib35', 'doi-asserted-by': 'crossref', 'first-page': '913', 'DOI': '10.1016/S0149-2918(97)80045-8', 'article-title': 'Comparison of hydroxychloroquine with zidovudine in asymptomatic ' 'patients infected with HIV-1', 'volume': '19', 'author': 'Sperber', 'year': '1997', 'journal-title': 'Clin Ther'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib36', 'unstructured': 'Debiaggi M, Bruno R, Sacchi P, Filice G. Antiviral activity of ' 'chloroquine against HIV-1 strains resistant to antiretroviral drugs. ' 'Antiviral Res (in press)'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib37', 'doi-asserted-by': 'crossref', 'first-page': '1080', 'DOI': '10.1016/S0149-2918(96)80063-4', 'article-title': 'Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of ' 'action and comparison with zidovudine', 'volume': '18', 'author': 'Chiang', 'year': '1996', 'journal-title': 'Clin Ther'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib38', 'doi-asserted-by': 'crossref', 'first-page': '1224', 'DOI': '10.1016/S0140-6736(05)60566-1', 'article-title': 'Antiretroviral therapy', 'volume': '352', 'author': 'Boelaert JR and Sperber', 'year': '1998', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib39', 'doi-asserted-by': 'crossref', 'first-page': '1531', 'DOI': '10.1016/S0006-2952(01)00576-7', 'article-title': 'Chloroquine exerts an additive in vitro anti-HIV-1 effect, when ' 'combined to zidovudine and hydroxyurea', 'volume': '61', 'author': 'Boelaert', 'year': '2001', 'journal-title': 'Biochem Pharmacol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib40', 'doi-asserted-by': 'crossref', 'first-page': '1667', 'DOI': '10.1016/S0140-6736(02)08557-4', 'article-title': 'Hydroxychloroquine, hydroxycarbamide, and didanosine as economic ' 'treatment for HIV-1', 'volume': '359', 'author': 'Paton', 'year': '2002', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib41', 'doi-asserted-by': 'crossref', 'first-page': '2221', 'DOI': '10.1097/00002030-200211080-00016', 'article-title': 'The boosting of didanosine by allopurinol permits a halving of the ' 'didanosine dosage', 'volume': '16', 'author': 'Boelaert', 'year': '2002', 'journal-title': 'AIDS'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib42', 'doi-asserted-by': 'crossref', 'first-page': '2237', 'DOI': '10.1016/S0140-6736(00)02415-6', 'article-title': 'Advances and research directions in the prevention of mother-to-child ' 'HIV-1 transmission', 'volume': '355', 'author': 'Mofenson', 'year': '2000', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib43', 'doi-asserted-by': 'crossref', 'first-page': '2205', 'DOI': '10.1097/00002030-200111090-00024', 'article-title': 'Chloroquine accumulates in breast milk cells. Potential impact as ' 'adjuvant to antiretroviral prophylaxis for postnatal mother-to-child ' 'transmission of HIV-1', 'volume': '15', 'author': 'Boelaert', 'year': '2001', 'journal-title': 'AIDS'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib44', 'doi-asserted-by': 'crossref', 'first-page': '1175', 'DOI': '10.1001/jama.283.9.1175', 'article-title': 'Prevention of mother-to-child transmission of HIV-1 in resource-poor ' 'countries: translating research into policy and practice', 'volume': '283', 'author': 'DeCock', 'year': '2000', 'journal-title': 'JAMA'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib45', 'doi-asserted-by': 'crossref', 'first-page': '2177', 'DOI': '10.1016/S0140-6736(02)09095-5', 'article-title': 'HIV-1/AIDS and the control of other infectious diseases in Africa', 'volume': '359', 'author': 'Corbett', 'year': '2002', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib46', 'doi-asserted-by': 'crossref', 'first-page': '2083', 'DOI': '10.1097/00002030-200009290-00003', 'article-title': 'Immune activation in Africa is environmentally driven and is associated ' 'with upregulation of CCR5', 'volume': '14', 'author': 'Clerici', 'year': '2000', 'journal-title': 'AIDS'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib47', 'doi-asserted-by': 'crossref', 'first-page': '2071', 'DOI': '10.1097/00002030-200009290-00002', 'article-title': 'Concurrent infections and HIV pathogenesis', 'volume': '14', 'author': 'Bentwich', 'year': '2000', 'journal-title': 'AIDS'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib48', 'doi-asserted-by': 'crossref', 'first-page': '76', 'DOI': '10.1086/315185', 'article-title': 'Elevated tumor necrosis factor-α activation of human immunodeficiency ' 'virus subtype 1 in southern Africa is associated with an NF-kB enhancer ' 'gain-of-function', 'volume': '181', 'author': 'Montano', 'year': '2000', 'journal-title': 'J Infect Dis'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib49', 'doi-asserted-by': 'crossref', 'first-page': '1995', 'DOI': '10.1056/NEJMoa030634', 'article-title': 'Identification of severe acute respiratory syndrome in Canada', 'volume': '348', 'author': 'Poutanen', 'year': '2003', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib50', 'doi-asserted-by': 'crossref', 'first-page': '1615', 'DOI': '10.1016/S0140-6736(03)13265-5', 'article-title': 'Development of a standard treatment protocol for severe acute ' 'respiratory syndrome', 'volume': '361', 'author': 'So', 'year': '2003', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib51', 'doi-asserted-by': 'crossref', 'first-page': '1319', 'DOI': '10.1016/S0140-6736(03)13077-2', 'article-title': 'Coronavirus as a possible cause of severe acute respiratory syndrome', 'volume': '361', 'author': 'Peiris', 'year': '2003', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib52', 'doi-asserted-by': 'crossref', 'first-page': '1967', 'DOI': '10.1056/NEJMoa030747', 'article-title': 'Identification of a novel coronavirus in patients with severe acute ' 'respiratory syndrome', 'volume': '348', 'author': 'Drosten', 'year': '2003', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib53', 'series-title': 'The Nidoviruses, Coronaviruses and Arteriviruses', 'first-page': '193', 'article-title': 'Human Coronavirus HCoV-229E enters susceptible cells via the endocytic ' 'pathway', 'author': 'Blau', 'year': '2001'}, { 'issue': 'Pt 2', 'key': '10.1016/S1473-3099(03)00806-5_bib54', 'doi-asserted-by': 'crossref', 'first-page': '297', 'DOI': '10.1099/0022-1317-80-2-297', 'article-title': 'Entry of porcine reproductive and respiratory syndrome virus into ' 'porcine alveolar macrophages via receptor-mediated endocytosis', 'volume': '80', 'author': 'Nauwynck', 'year': '1999', 'journal-title': 'J Gen Virol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib55', 'doi-asserted-by': 'crossref', 'first-page': '1767', 'DOI': '10.1016/S0140-6736(03)13412-5', 'article-title': 'Clinical progression and viral load in a community outbreak of ' 'coronavirus-associated SARS pneumonia: a prospective study', 'volume': '361', 'author': 'Peiris', 'year': '2003', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib56', 'doi-asserted-by': 'crossref', 'first-page': '40', 'DOI': '10.1016/1357-4310(95)80019-0', 'article-title': 'The role of cytokines and adhesion molecules in the development of ' 'inflammatory injury', 'volume': '1', 'author': 'Shanley', 'year': '1995', 'journal-title': 'Mol Med Today'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib57', 'doi-asserted-by': 'crossref', 'first-page': '1773', 'DOI': '10.1016/S0140-6736(03)13413-7', 'article-title': 'Lung pathology of fatal severe acute respiratory syndrome', 'volume': '361', 'author': 'Nicholls', 'year': '2003', 'journal-title': 'Lancet'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib58', 'doi-asserted-by': 'crossref', 'first-page': '161', 'DOI': '10.1016/S0165-2427(02)00047-8', 'article-title': 'In vivo studies on cytokine involvement during acute viral respiratory ' 'disease of swine: troublesome but rewarding', 'volume': '87', 'author': 'Van Reeth', 'year': '2002', 'journal-title': 'Vet Immunol Immunopathol'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib59', 'doi-asserted-by': 'crossref', 'first-page': '312', 'DOI': '10.1086/321889', 'article-title': 'Risks factors and prevention of Q fever endocarditis', 'volume': '33', 'author': 'Fenollar', 'year': '2001', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib60', 'doi-asserted-by': 'crossref', 'first-page': '275', 'DOI': '10.1097/00002030-200301240-00025', 'article-title': 'Malaria, HIV and pregnancy', 'volume': '17', 'author': 'Ladner', 'year': '2003', 'journal-title': 'AIDS'}, { 'key': '10.1016/S1473-3099(03)00806-5_bib61', 'doi-asserted-by': 'crossref', 'first-page': '1079', 'DOI': '10.1097/00002030-200006160-00004', 'article-title': 'Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation ' 'or an active player in virus/host interactions?', 'volume': '14', 'author': 'Savarino', 'year': '2000', 'journal-title': 'AIDS'}], 'container-title': 'The Lancet Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': '', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': '', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 4, 27]], 'date-time': '2023-04-27T08:30:22Z', 'timestamp': 1682584222000}, 'score': 1, 'resource': {'primary': {'URL': ''}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2003, 11]]}, 'references-count': 61, 'journal-issue': {'issue': '11', 'published-print': {'date-parts': [[2003, 11]]}}, 'alternative-id': ['S1473309903008065'], 'URL': '', 'relation': {}, 'ISSN': ['1473-3099'], 'subject': [], 'container-title-short': 'The Lancet Infectious Diseases', 'published': {'date-parts': [[2003, 11]]}}
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop